{"schema_version":"secwatch.filing_event.v1","accession":"0001722482-21-000194","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.379004+00:00","generated_at":"2026-06-30T04:31:40.561838+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.18,"calibrated_materiality_score":0.18,"confidence":"high","headline":"Avantor appoints John Carethers, M.D. as independent Class III director","bullets":["John Carethers, M.D., age 57, appointed to serve as Class III director with term expiring at 2022 annual meeting.","Carethers is Chair, Department of Internal Medicine at University of Michigan Medical School; member of National Academy of Medicine.","Standard non-employee director compensation: prorated $75,000 annual cash retainer and prorated $200,000 RSU grant.","RSUs vest one year from grant date, subject to continued service; board has determined independence under NYSE standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001722482-21-000194","json":"https://secwatch.observer/filing/0001722482-21-000194.json","markdown":"https://secwatch.observer/filing/0001722482-21-000194.md","text":"https://secwatch.observer/filing/0001722482-21-000194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000194/0001722482-21-000194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000194/avtr-20210715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:31:40.561838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3cbb7f4437","claim":"John Carethers, M.D. was appointed as Director at Avantor, Inc..","evidence_excerpt":"On July 15, 2021, the Board, upon the recommendation of its Nominating and Governance Committee, appointed John Carethers, M.D. as a Class III director with an initial term expiring at the Company’s 2022 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000172248221000194/0001722482-21-000194-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}